Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at December 31, 2018 (audited) at Dec. 31, 2018 $ 5,725 $ 148,888,635 $ (121,370,240) $ 27,524,120
Beginning balance, shares at Dec. 31, 2018 57,247,496      
Stock-based compensation expense 8,884,001 8,884,001
Issuance of common stock, net of issuance costs of $2,571,552 $ 620 37,718,078 37,718,698
Issuance of common stock, net of issuance costs of $2,571,552, shares 6,198,500      
Issuance of common stock upon exercise of stock options $ 10 386,801 386,811
Issuance of common stock upon exercise of stock options, shares 107,029      
Issuance of common stock upon exercise of warrants $ 112 (112)
Issuance of common stock upon exercise of warrants, shares 1,119,868      
Net loss (44,872,957) (44,872,957)
Balance at September 30, 2019 (Unaudited) at Sep. 30, 2019 $ 6,467 195,877,403 (166,243,197) 29,640,673
Ending balance, shares at Sep. 30, 2019 64,672,893      
Balance at December 31, 2018 (audited) at Jun. 30, 2019 $ 6,465 192,819,731 (145,452,396) 47,373,800
Beginning balance, shares at Jun. 30, 2019 64,644,093      
Stock-based compensation expense 2,977,574 2,977,574
Issuance of common stock upon exercise of stock options $ 2 80,098 80,100
Issuance of common stock upon exercise of stock options, shares 28,800      
Net loss (20,790,801) (20,790,801)
Balance at September 30, 2019 (Unaudited) at Sep. 30, 2019 $ 6,467 195,877,403 (166,243,197) 29,640,673
Ending balance, shares at Sep. 30, 2019 64,672,893      
Balance at December 31, 2018 (audited) at Dec. 31, 2019 $ 6,467 198,975,056 (192,823,958) 6,157,565
Beginning balance, shares at Dec. 31, 2019 64,672,893      
Stock-based compensation expense 10,116,775 10,116,775
Issuance of common stock, net of issuance costs of $2,571,552 $ 1,728 114,560,514 114,562,242
Issuance of common stock, net of issuance costs of $2,571,552, shares 17,284,934      
Issuance of common stock upon exercise of stock options $ 25 574,208 $ 574,233
Issuance of common stock upon exercise of stock options, shares 249,578     249,578
Fair value of warrant issued in connection with K2HV agreement 472,409 $ 472,409
Net loss (102,657,472) (102,657,472)
Balance at September 30, 2019 (Unaudited) at Sep. 30, 2020 $ 8,220 324,698,962 (295,481,430) 29,225,752
Ending balance, shares at Sep. 30, 2020 82,207,405      
Balance at December 31, 2018 (audited) at Jun. 30, 2020 $ 8,065 308,991,895 (260,586,081) 48,413,879
Beginning balance, shares at Jun. 30, 2020 80,655,848      
Stock-based compensation expense 3,630,996 3,630,996
Issuance of common stock, net of issuance costs of $2,571,552 $ 150 11,331,739 11,331,889
Issuance of common stock, net of issuance costs of $2,571,552, shares 1,504,473      
Issuance of common stock upon exercise of stock options $ 5 271,923 271,928
Issuance of common stock upon exercise of stock options, shares 47,084      
Fair value of warrant issued in connection with K2HV agreement 472,409 472,409
Issuance of common stock upon exercise of warrants, shares      
Net loss (34,895,349) (34,895,349)
Balance at September 30, 2019 (Unaudited) at Sep. 30, 2020 $ 8,220 $ 324,698,962 $ (295,481,430) $ 29,225,752
Ending balance, shares at Sep. 30, 2020 82,207,405